New Research Reveals How Alzheimer's Disease Affects Multiple Body Systems
New research uncovers how Alzheimer's disease proteins impact aging, metabolism, and gut health, revealing systemic effects beyond the brain.
Research indicates that Alzheimer's disease impacts not only the brain but also influences aging, fat metabolism, and gut health. A recent study using fruit flies shows that proteins linked to Alzheimer's, such as amyloid-beta and tau, can accelerate biological aging and cause widespread effects on organs beyond the nervous system. The study uncovered mechanisms involving systemic inflammation, metabolic changes, and communication pathways between the brain and peripheral tissues. These findings suggest that Alzheimer's is a systemic disease with effects extending to various body functions, highlighting the importance of holistic approaches to understanding and potentially treating the condition.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Virtual Ward Beds Significantly Reduce Carbon Footprint Compared to Traditional Inpatient Beds
A recent study reveals that virtual ward beds emit four times less carbon than traditional hospital inpatient beds, offering a sustainable approach to healthcare and helping the NHS reach its net-zero goals.
Revolutionizing Neuroscience with High-Speed Automated Neuronal Electrophysiology
A groundbreaking high-speed, automated method for studying neurons in their natural state offers new opportunities for advancing neuroscience and drug discovery. Developed by Yale researchers, this technique enables rapid, unbiased electrophysiological analysis of large neuronal populations, enhancing research efficiency and accuracy.
Winter Respiratory Viruses 2025: Tracking COVID, Flu, and RSV and How to Stay Protected
Stay informed on the latest trends in COVID-19, flu, and RSV cases this winter and learn essential protective strategies to stay safe and healthy during the season.
Maintenance Combination of Lurbinectedin and Atezolizumab Improves Survival in Lung Small Cell Carcinoma
A combination of lurbinectedin and atezolizumab as maintenance therapy significantly improves survival in extensive-stage small cell lung cancer, according to new research presented at ASCO 2025.